Funded Artificial Intelligence Startups in Salt Lake City
Salt Lake City's AI funding activity spans a wide spectrum of stages, with the 12 rounds shown here ranging from September 2020 through September 2025.
Salt Lake City's AI funding activity spans a wide spectrum of stages, with the 12 rounds shown here ranging from September 2020 through September 2025. Recursion Pharmaceuticals dominates by dollar volume — $239M in September 2020 followed by a $150M post-IPO equity round in October 2022, reflecting its status as a publicly traded AI drug-discovery company. The most recent large raise is PassiveLogic's $74M Series C, closed in September 2025, with Moises ($30M) and Jump (Series A, $20M) adding further 2025 activity.
The 2023 cohort — Gauge ($9M), Altitude AI ($4M), OMNIQ ($3M), and Qualiti ($3M) — shows a set of smaller institutional rounds clustered within a single calendar year. Six of the twelve rounds carry no disclosed round type, which limits stage comparisons but signals a mix of structures common in mid-market venture activity. MURF.AI's $10M Series A (September 2022) and DeepSee.ai's $23M Series A (March 2021) fill out the earlier part of the timeline.
Most recent rounds
12 shownRelated listings
Frequently asked
What are the largest rounds among Salt Lake City AI startups in this dataset?
Recursion Pharmaceuticals accounts for the two largest — $239M in September 2020 and $150M in post-IPO equity in October 2022. PassiveLogic's $74M Series C in September 2025 is the largest disclosed venture round in the more recent window.
Which Salt Lake City AI companies have raised rounds in 2025?
Three companies in this set raised in 2025: PassiveLogic closed a $74M Series C in September 2025, Moises raised $30M in May 2025, and Jump completed a $20M Series A in February 2025.
Do Salt Lake City AI rounds skew early-stage or later-stage?
The 12 rounds shown lean early-stage — three are classified as Series A (Jump, MURF.AI, DeepSee.ai), one as Series C (PassiveLogic), and six carry no disclosed round type. Only Recursion Pharmaceuticals represents a post-IPO stage.
Was 2023 a notably active year for AI funding in Salt Lake City?
Four rounds closed in 2023 — Gauge ($9M in March), Altitude AI ($4M in January), OMNIQ ($3M in October), and Qualiti ($3M in December) — the highest count for any single year in this dataset, though all were sub-$10M raises.
Is Recursion Pharmaceuticals the only publicly traded AI company in this set?
Based on the data shown, yes. Recursion Pharmaceuticals appears twice — a $239M raise in September 2020 and a $150M post-IPO equity round in October 2022 — and is the only company in this dataset with a post-IPO round type listed.
How wide is the deal size range across Salt Lake City AI rounds?
Disclosed amounts span from $3M (Qualiti and OMNIQ, both late 2023) to $239M (Recursion Pharmaceuticals, 2020). One round — Vanilla in August 2024 — carries an undisclosed amount. Excluding Recursion Pharmaceuticals, all remaining disclosed rounds fall between $3M and $74M.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.